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ABSTRACT
Motivation: The process of producing microarray data involves
multiple steps, some of which may suffer from technical problems
and seriously damage the quality of the data. Thus, it is essential to
identify those arrays with low quality. This article addresses two
questions: (1) how to assess the quality of a microarray dataset using
the measures provided in quality control (QC) reports; (2) how to
identify possible sources of the quality problems.
Results: We propose a novel multivariate approach to evaluate the
quality of an array that examines the ‘Mahalanobis distance’ of its
quality attributes from those of other arrays. Thus, we call it
Mahalanobis Distance Quality Control (MDQC) and examine different
approaches of this method. MDQC flags problematic arrays based
on the idea of outlier detection, i.e. it flags those arrays whose quality
attributes jointly depart from those of the bulk of the data. Using two
case studies, we show that a multivariate analysis gives substantially
richer information than analyzing each parameter of the QC report in
isolation. Moreover, once the QC report is produced, our quality
assessment method is computationally inexpensive and the results
can be easily visualized and interpreted. Finally, we show that
computing these distances on subsets of the quality measures in the
report may increase the method’s ability to detect unusual arrays
and helps to identify possible reasons of the quality problems.
Availability: The library to implement MDQC will soon be available
from Bioconductor
Contact: gcohen@mrl.ubc.ca
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Microarray technologies have enabled researchers to monitor
the expression levels of tens of thousands of genes simulta-
neously. However, the process of producing microarray data,
from sample preparation to the final step of harvesting the
data, involves multiple steps, some of which can be error-prone.
Possible quality problems include poor RNA extraction,
problems arising from the hybridization process, physical
defects of the chips, and artifacts such as batching effects
(see Zhang et al., 2004 and Brettschneider et al., 2007 for
a more detailed discussion). As poor quality arrays may
seriously distort the preprocessing as well as the data analysis
procedures, examining the quality of the arrays is a critical step
before any subsequent analysis can be performed. In this
article, the first question we consider is how to assess the
quality of a large microarray dataset. That is, after we receive n
microarray chips from a facility that produces microarray data,
we need to assess their quality, and if necessary, to identify
those m chips that need to be rerun. The second question we
consider is why each of the m chips is of unacceptable quality.
Because of the resources involved (e.g. biological material,
human time and production cost), this is an important step to
reduce the effort required for the rerun.
Despite the extensive research on microarray data, the
development of microarray quality assessment methods is still
in its early stages. The standard practice of inspecting each
image files to detect quality problems of each array is time
consuming and difficult to apply in large studies. As a result,
alternative automated quality assessment methods have been
proposed. We briefly discuss some of these studies and refer the
reader to Brettschneider et al. (2007) for a comprehensive
review of the literature. For spotted arrays, several studies
provide useful spot quality measures to examine features of
each spot on the slides (Bylesjo¨ et al., 2005; Hautaniemi et al.,
2003; Sauer et al., 2005; Wang et al., 2001). In addition, Model
et al. (2002) propose using multivariate statistical process
control techniques based on the measurement values of cDNA
arrays to detect problematic slides. For oligonucleotide arrays,
quality control (QC) reports can be used to assess the quality of
the arrays (Affymetrix 2004; Wilson and Miller 2005). Instead
of relying on QC reports, Brettschneider et al. (2007) introduce*To whom correspondence should be addressed.
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several new quality measures based on probe level and probeset
level information to assess the quality of Affymetrix GeneChips
(Bolstad et al., 2005).
In this article, we develop a tool to identify quality problems
based on the quality measures provided in any QC report.
Although there is an open debate on whether the measures
contained in the QC reports can identify quality problems, QC
reports are commonly used to assess the quality of microarrays
(Finkelstein, 2005; Landea et al., 2005). One common practice
is to compare the values of each measure against ad hoc
thresholds. Another practice is to account for the similarity of
the measures across arrays and flag those arrays with one or
more measures that substantially differ from those of the
majority of the arrays. These methods can be implemented
using softwares such as simpleaffy (Wilson and Miller,
2005) or GeneData Expressionist Refiner 5.0 (GeneData, Basel,
Switzerland). The main drawback of these methods is that they
are univariate, i.e. they ignore the correlation structure of the
QC measures. As a result, these methods can only detect
univariate outliers, i.e. observations that clearly depart from the
bulk of the data in at least one dimension. However, they
cannot detect structural outliers, i.e. observations that are not
outliers in any single dimension, but are nonetheless outliers
when multiple dimensions are considered (see Rousseeuw and
Leroy 1987 or Model et al., 2002 for a discussion of this issue).
In our context, we are interested in flagging arrays that violate
any of the univariate checks, but also those that are of poor
quality only when multiple QC parameters are simultaneously
taken into account.
We propose a multivariate quality assessment method for
microarrays that is based on the similarity of quality measures
across arrays, i.e. on the idea of outlier detection. Intuitively,
the ‘distance’ of an array’s quality attributes measures the
similarity of the quality of that array against the quality of the
other arrays. Then, arrays with unusually high distances can be
flagged as potentially low quality. Thus, our method computes
a single distance measure, the Mahalanobis distance (MD),
to summarize the quality of each array. The use of this distance
allows us to perform a multivariate analysis of the information
in QC reports taking the correlation structure of the quality
measures into account. In addition, by using robust estimators
to identify the typical quality measures of good-quality arrays,
the evaluation is not affected by the measures of outlying
arrays. This method can be based on all the quality measures
simultaneously, or on subsets of them, which gives one distance
value for each subset of parameters in the QC report. We show
that the latter approach can be exploited to provide possible
explanations of the source of the quality problems. In sum,
we bring outlier detection methods widely used in statistics into
the quality assessment of microarrays based on QC measures.
The method is specifically designed to identify a small
fraction of potentially flawed arrays within a large set of arrays.
Thus, it is useful to deal with the common problem that arises
in microarray experiments when a small number of the arrays
in the batch may have low quality and need to be identified.
The method is not appropriate when a large fraction of the
arrays or even the entire batch may be flawed due to incorrect
laboratory procedures, contaminated samples or other reasons.
However, such events can be easily detected using the
univariate methods discussed above.
In addition to having a clear statistical foundation, our
method has several salient features. First, it takes into account
the correlation structure of the quality parameters in the QC
report. We show that a multivariate analysis gives substantially
richer information than the analysis of each parameter in
isolation. Second, it is flexible and useful for any platform as it
can be based on any QC report. We illustrate our method using
two datasets of Affymetrix GeneChips and the QC reports
generated by simpleaffy (Wilson and Miller, 2005 and
GeneChip Operating Software (GCOS) (Affymetrix, 2005)
respectively. However, all the ideas can be applied to other
QC reports. Moreover, the user can choose how to group the
different quality measures as well as the cutoff lines. Third,
since our method is scale-invariant, the analysis does not
change if different scales are used for the quality parameters.
Last, once the QC reports are produced, our method is
computationally light-weight and it summarizes the large
number of quality parameters in a way that can be easily
visualized and interpreted, which is especially valuable in large
microarrays studies.
2 METHODS
2.1 Mahalanobis distances and quality control
Our method to assess the quality of an array is based on the MD
(Mahalanobis, 1936) of its quality measures from those of the majority
of the arrays. Thus, we refer to it as Mahalanobis Distance Quality
Control (MDQC) and it can be described as follows. Let
Xi¼ (Xi1,. . .,Xip), for i¼ 1, . . . , n and p5n, be p numeric1 measures
of the QC report for the ith array or p linear combinations of these
measures obtained from a Principal Component Analysis (PCA). Let X
be n times p matrix containing Xi in its rows, one for each array in the
study. Also let M be a p-dimensional row vector and S a p times p
positive definite matrix containing estimates of the center and
covariance matrix of X, respectively. Then, the MD of array i’s quality
measures from those corresponding to all the arrays characterized byM
and S, d(Xi;M,S), is defined by
dðXi;M;SÞ ¼ Xi Mð ÞS1 Xi Mð ÞT
 1=2 ð1Þ
Since we want to accurately compute the MD of one array’s quality
measures to those of other arrays, it is extremely important that outlying
arrays do not contaminate our estimates of the center and correlation
structure of all the arrays. If they did, then such distances would diverge
from their true values simply because the reference point is imprecisely
estimated and would not be useful in flagging problematic arrays. Thus,
our method relies on robust M (location) and S (scatter) estimators to
compute the MD defined in Equation (1). In Supplementary Material,
we illustrate the relevance of using robust estimators to compute the
MDs with a real data example. In this article, we use the S-estimator
(Lopuhaa¨, 1989), however, any other robust multivariate location and
scatter estimator can be used (e.g. minimum volume ellipsoid or
minimum covariance determinant estimators). To increase the finite
sample efficiency of these estimators and thus improve the approxima-
tion of the MDs distribution, we suggest using an estimator with 25%
breakdown point. This is particularly important in studies containing a
1Note that the QC report may also contain some non-numeric measure
(e.g. ‘Spikes Decr’ in GCOS QC reports) that should be inspected
separately.
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small number of arrays where the robust estimators are more unstable
and the distributional approximations are less accurate.
The resulting MDs can be used to flag poor-quality arrays as their
MDs will be large relative to those of undamaged arrays, i.e. they will
be far from the center of the normal arrays. Assuming that X1, . . ., Xp
are multivariate normal random variables, the squared MDs have an
approximate chi-squared distribution with p degrees of freedom. Thus,
using the chi-squared distribution we can set a cutoff point to decide if
the array is likely to be defective. For example, let X be a 20 times 14
matrix containing the 14 numeric quality measures of the GCOS QC
report for 20 arrays in a study. Then,M is a 14-dimensional row vector
that estimates the center of X and S is a 14 times 14 matrix that
estimates its covariance matrix. Finally, the MDs would be distributed
as a chi-squared with 14 degrees of freedom.
2.2 MDQC: different approaches
The most intuitive approach towards MDQC is to compute a single
MD for each array based on all the quality measures in the QC report.
However, this approach suffers from two drawbacks, one statistical and
one conceptual. First, the low quality of an array may be reflected by
extreme values in only a few of the measures in the report, while other
measures may not significantly differ from those corresponding to the
bulk of the arrays. Thus, it is possible that the combination of all the
quality measures into a single MD ‘masks’ these outlying observations.
Second, even when a single MD can be accurate in identifying poor
quality arrays, it provides no information about the potential source of
the quality problem. Thus, we recommend alternative approaches to
address these issues.
Computing multiple MDs based on different groups with a reduced
number of quality measures instead of a single MD based on all of them
can help to ‘unmask’ outlying observations. As a result, the quality
attributes of an array would be summarized by as many MDs as groups
formed. In addition, QC reports usually contain more than one measure
related to the same quality aspect of the array. Thus, grouping
complementary measures according to the quality attribute they
represent helps to identify possible reasons of the quality problems.
We recommend to form these groups using the a priori grouping
method, in which the groups are formed on the basis of an a priori
interpretation of the quality measures in the report and according to the
quality aspect they represent. To illustrate the use of this method, we
now use the GCOS QC report for Affymetrix GeneChip arrays
(Affymetrix, 2005). The QC measures in this report can be classified
into four groups, according to whether they provide information on the
quality of the chip and/or the sample, the chip, the sample and the
RNA, respectively:
(1) RawQ, Noise, Background, Scale Factor and PercPresent
(2) Cornerþ , Corner , Central
(3) BioB, BioC, BioDN and CreX
(4) GapDH and B-Actin.
Then, we compute four MDs for an array, one for each group of quality
measures. The MDQC method based on these a priori groups flags an
array as potentially low quality if one or more of its MDs are
abnormally high.
These groups contain valuable information about the possible
sources of corruption. For example, if only the MD for Group
4 were abnormally high, then this would suggest that the array is
defective due to poor RNA quality. However, the groups may
sometimes provide less conclusive evidence about the source of the
problem as a high MD in one group may manifest itself together with
an abnormal MD in other groups. For example, a defective chip that
should give large MDs in Group 2 may distort the expression of the
housekeeping genes and thus also give large MDs in Group 3.
Nevertheless, even in these cases the a priori approach usually allows
the researcher to rule out at least some possible sources of corruption.
The MDQC method based on groups is versatile. The a priori
approach described above can also be used on QC reports other than
that provided by GCOS. This would result in different a priori groups
based on the description of each measure in those reports. In addition,
in the Supplementary Material we provide two data-driven methods to
form the groups that serve as an alternative to the a priori approach.
These are the clustering grouping method, which groups the quality
measures using clustering analysis, and the loading PCA grouping
method, which uses the loadings of a PCA to identify the quality
measures that contain similar information. It is important to note that
the groups formed using these approaches will vary from one dataset to
another, and one may lose the interpretability of the groups provided
by the a priori method.
We also propose an alternative approach to unmask low-quality
arrays, which we refer to as the global PCA method. It uses PCA to
create linear combinations of the original QC parameters, referred to as
principal components (PCs), where the PCs retain most of the original
variability in the data (Johnson and Wichern, 1999). Thus, the MD can
be computed on a single group based on the reduced space of the first
k PCs (k5p), which can help to ‘unmask’ outlying observations. It is
important to note that, in this approach, the formed group does not
contain a subset of the original quality measures sharing a common
purpose as in the a priori groups. Thus, while this method can also flag
low-quality arrays, it gives no indication of the source of the quality
problem.
In a PCA, it is usually recommended to standardize the data by the
mean and SD of each variable so that variables with a large variance
will not dominate the first PCs (Johnson and Wichern, 1999).
In addition, as the QC report may contain outlying measures associated
with low-quality arrays, it is important to use a robust multivariate
location and scatter estimator to standardize the variables. Thus, let X
be a n times p matrix containing the quality parameters of each array in
each row, and let (M,S) be the robust location and scatter estimator of
X. Then, the standardized variables are given by ZTi ¼ V1=2ðXi MÞT,
for i¼ 1 ,. . . ,n, where V is a p times p diagonal matrix containing the
robust variance estimates. If n4p, a robust PCA can be performed
deriving the PCs from a robust location and covariance matrix
estimators of Z, where Z is the n times p matrix with Zi in its rows
(Croux and Heasbroeck, 2000)2. That is, the j th PC is given by Yj¼Zej,
where ej is the eigenvector corresponding to the jth largest eigenvalue j
of the covariance matrix of Z, for j¼ i,. . .,p.
If we use the same robust multivariate estimator to standardize the
data, to derive the PCs and to estimate the PC’s location and covariance
matrix, then the estimated PC’s location and covariance matrix become
a zero vector, 0p, and a diagonal matrix with the eigenvalues j in its
diagonal, Dp¼diag{1,. . .,p}, respectively. As a result, the MDs
defined in Equation (1) reduces to an Euclidean distance weighted by
the eigenvalues of the covariance matrix of Z (Johnson and Wichern,
1999). i.e.
dð ~Xi; 0k;DkÞ ¼
Xk
j¼1
Y 2i j
j
" #1=2
ð2Þ
where ~Xi ¼ ðYi1; . . . ;YikÞ is the set of the first k PCs for the ith array.
In this article, we use the S-estimator with 25% breakdown point in
all the steps of the analysis, however, other robust estimators can be
used. The scree plot (i.e., the plot of j in decreasing order versus j, for
j¼ 1, . . . ,p) is used to determine the number k of principal components
preserved in the analysis, looking for the ‘elbow’ or first important bend
2Robust PCA methods when p4n can be found in Huber et al. (2002).
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in the line (Johnson and Wichern, 1999). As before, we flag the array
as potentially low quality if its distance defined in Equation (2) is
unusually high.
3 RESULTS AND DISCUSSION
We use two case studies to evaluate the performance of the
MDQC method. The first dataset is part of an acute
lymphoblastic leukemia study described by Ross et al. (2003)
and contains 20 Affymetrix HG-U133B microarrays. Bolstad
et al. (2005) and Brettschneider et al. (2007) examined the
quality of these arrays using histograms of probe-level data,
MA-plots and probe-level model (PLM) methods (PLM).3
According to their quality assessment, array 2 has a strong
spatial artifact on the chip and array 14 presents other evidence
of poor quality. Because of the existence of such ‘ground
truths’, we first present the comparative analysis based on this
small dataset. Our second dataset consists on 201 Affymetrix
GeneChip Human Genome U133 Plus 2.0 on RNA isolated
from whole blood of patients who have undergone kidney, liver
or heart transplants. This dataset is owned by us, allowing us
the opportunity to follow up on various aspects and to perform
reruns. The analysis of both datasets was performed in R. The
corresponding codes and QC reports are available upon
request. In addition, the library to implement the MDQC
method will soon be publicly available from Bioconductor.
3.1 Acute lymphoblastic leukemia study
Figure 1 illustrates the measures of the QC report generated by
the R-package simpleaffy for 20 microarrays of the acute
lymphoblastic leukemia study. A univariate analysis of these
measures based on Affymetrix recommended thresholds
(Affymetrix, 2004) flags some of the arrays as having
potentially low quality and are identified using solid points.
In particular, arrays 6, 8 and 10 have a ‘scale factor’ value
above usual threshold of 10 and arrays 6 and 8 have also a
‘percent present’ value below 20. Array 14 has all background
measures (average, minimum and maximum background)
above usual threshold of 100. In addition, array 2 has a
‘maximum background’ value above this threshold. The values
of the spiked hybridization controls (bioB, bioC, bioD and cre)
are low for array 14, though they are always present with
increasing signal values as recommended by Affymetrix. Note
that arrays 1 and 7 has problems similar to those of array 14,
though to a lesser extent. Finally, array 8 shows high values for
the last two quality measures corresponding to RNA house-
keeping genes. However, both values are below the recom-
mended threshold of 2.
We now compare the previous univariate analysis with a
multivariate one using MDQC based on all the quality measures
in the report. Figure 2 shows that using this MDQC approach
array 14 is flagged as having potential quality problems and
array 2 appears only as a borderline case. Thus, collapsing all
the quality measures into a single MD downweights array 2’s
quality problems and masks other outlying observations in the
QC report, such as those of arrays 1, 7 or 8. Thus, we study the
MDs on groups with a reduced number of variables such as
those created by the a priori grouping method and the group of
the first principal components. As it was previously discussed,
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Fig. 1. Quality measures for the acute lymphoblastic leukemia study: univariate analysis. Arrays that do not pass recommended thresholds are
identified using solid points. The x axis contains the index of each array and the y axis shows the different quality measures contained in the report in
their original scale.
3Note that the ID numbers used here are not the same as the ones used
in previous references. However, array 2 in this study corresponds to
array a in Bolstad et al. (2005) and 15 in Brettschneider et al. (2007).
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these alternative methods reduce the possibility of masking
outliers and may give information about the potential source of
the quality problem.
Using the a priori grouping method, MDQC examines three
MDs, one for each of the following three groups:
(1) Scale Factor, % Present, Avg BG, Min BG, Max BG
(2) BioB, BioC, BioD, CreX
(3) AFFX-HSAC07/X00351.30/50, GapDH.
Note that the quality measures of Group 2 in Section 2.2 are
not available in the simpleaffy QC report, thus, there are
only three groups to examine. These groups can be used to
assess the quality of the chip/sample, the sample and the RNA,
respectively. Each plot in Figure 3 shows the MD (y=axis) of
each array (x=axis) within each a priori group. The solid,
dashed and dotted lines correspond to the square root of the
90th, 95th and 99th percentile of the chi-squared distribution,
respectively.
In Group 1, arrays 2 and 14 are both flagged as potentially
defective, and array 17 as a borderline case. In Group 2, array
1 has an MD exceeding the 99% cutoff and arrays 7 and 14
have MDs exceeding the 95% cutoff line. Finally, array 8 is the
only one flagged in Group 3. Thus, the MDs based on groups
of lower dimension flag both arrays 2 and 14, which is
consistent with the results in Bolstad et al. (2005) and
Brettschneider et al. (2007). In addition, arrays 1 and 8 are
flagged as potentially low quality and arrays 7 and 17 as
borderline quality. Moreover, based on the interpretability of
the groups, the problems in array 2 are most likely due to
defects in the chip as this array is only identified in Group 1.
Similarly, since arrays 1 and 14 are flagged in Group 2, their
low quality is most likely due to low quality of the sample. Note
that although array 14 is also flagged in Group 1, this can still
be due to quality problems in the sample. Finally, array 8 is
flagged only in Group 3, suggesting potential problems in the
RNA quality. In the Supplementary Material, we also analyze
this dataset using MDQC based on the clustering grouping
method and the loading PCA grouping method. The groups
formed by these two data-driven methods almost validate the a
priori grouping described above, and thus the results are similar
to those reported in Figure 3.
Comparing the previous multivariate analysis with the
univariate one, it is important to note that besides the
‘maximum background’, all other quality measures for array
2 are similar to those of the other arrays (see all plots in Fig. 1).
Thus, without ‘maximum background’, the univariate analysis
does not identify this array as having quality problems.
However, the top-right plot in Figure 3 shows that MDQC
using the a priori grouping method still flags this array even
when the ‘maximum background’ is not included in the
analysis. This example illustrates that a multivariate analysis
can flag a problematic array that a univariate analysis cannot
detect. In addition, note that array 14 is flagged by both the
univariate and the multivariate analyses. However, although
the univariate analysis suggests that array 14 is more
problematic than array 2, i.e. many of its quality measures
are outlying, the MDQC using the a priori grouping method
ranks array 2 as having lower quality (the MD of array 2 is
larger than that of array 14 in Group 1). Thus, our MDQC
method not only flags unusual arrays but also ranks them in a
way that is not evident from the univariate analysis.
Finally, we examine the performance of MDQC using the
global PCA method to reduce the dimensionality of the data.
Using the scree plot, we retain k¼ 4 principal components in
this analysis (see Supplementary Material). Figure 4 shows the
results of the MDQC when a single MD is calculated based on
the first four PCs derived from a robust PCA based on robustly
standardized data (see Section 2.2). We note that this approach
still flags arrays 2, 8 and 14 as having potential quality
problems. However, the first two appear only as borderline
cases. In addition, arrays 1, 7 and 17 are still masked using this
method.
In sum, all three grouping approaches of MDQC (i.e. all
variables, the a priori grouping method and the global PCA
method) identify the problematic arrays 2 and 14 that were
previously detected by Bolstad et al. (2005) and Brettschneider
et al. (2007). However, the a priori grouping method outstands
the problem of array 2, unmasks other potentially low-quality
arrays and provides possible explanations of the quality
problems.
3.2 Transplantation study
We use this dataset to illustrate the performance of our method
in a large study with the ability to re-run potentially low-quality
arrays. The analysis is based on the 14 numerical quality
measures contained in the GCOS QC report for each array (see
Section 2.2). Based on the MDQC analysis of the 201 original
arrays, budget and sample material limitations, 22 arrays
flagged with potentially low quality have been re-run. While the
diagnostic of the original set is based on an analysis that does
5 10 15 20
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Fig. 2. Results of MDQC based on all measures of the QC report.
The MDs (y axis) are computed using the robust S-estimator for each
array (x axis). The solid, dashed and dotted lines correspond to the
square root of the 90th, 95th and 99th percentile of the chi-squared
distribution, respectively. Outlying arrays are identified using solid
points.
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not include the re-runs, to simplify the exposition, we include
the results of all the arrays in the same plot. Thus, Figure 5
shows the MDs (y axis) of the 223 arrays within each of the four
a priori groups defined in Section 2.2. We recall that Groups
1–4 provide information on the quality of the chip and/or
sample, the chip, the sample and the RNA, respectively. Solid
points are used to identify the 22 arrays that were re-run, solid
triangles for the re-runs and open triangles for those that could
not be re-run due to the lack of additional sample material. In
addition, the array’s IDs contain two numbers: the first one
corresponds to the patient ID and the second one to the
number of months after transplant. The re-run arrays are
labeled with an R after this numeric ID. For example, 21-4 is
the ID for the array corresponding to patient 21 at 4 months
after transplant, and 21-4R is its re-run. The solid, dashed and
dotted lines correspond to the square root of the 90th, 95th and
99th percentile of the chi-squared distribution, respectively.
Figure 5 shows the plots of the MDs in each of the four
groups. Although our method identifies several outlying arrays,
we focus our discussion on the subset of those arrays with the
highest MDs that we were able to re-run: 21-4, 17-6, 25-5, 302-7,
36-6, 21-2, 21-3, 5 arrays of patient 13 and 10 arrays of patient
317.
Arrays 21-4, 17-6, 25-5 and 302-7 have outlying MDs in
Groups 1–3, but not in Group 4. Thus, the quality problem may
come from the chip, the sample, or both, but not from the RNA
quality. To identify the source of the quality problem, we re-run
them using the same samplematerial but a new chip. As theMDs
of the re-run for array 21-4 (21-4R) are below the thresholds in
all four groups, we conclude that the original chip was damaged.
In contrast, the MDs of the re-runs of arrays 17-6, 25-5 and
302-7 continue to be flagged as outliers (data not shown),
suggesting that the original chips were not defective. The re-runs
of these arrays using new sample material give MDs that are
below the thresholds in all four groups. Thus, we conclude that
these arrays suffered from low-quality sample material. Further,
the array 36-6 has outlyingMDs in Groups 1 and 2, while arrays
21-2 and 21-3 have outlying MDs in Groups 1 and 3. We re-run
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these arrays using both new chips and new sample material and
our method ceased to flag them as low-quality arrays.
We additionally identify a set of arrays with unusual
indicators of RNA quality measures (see Group 4). These
arrays correspond to patients 13 and 317, although those for
the latter patient are borderline cases. As the arrays of both
patients were originally run in the same batch, these unusual
values can correspond to either a batch effect or a quality
problem in the RNA. We re-run each of these arrays in
different batches when RNA was still available. The re-run
arrays have MDs of the quality measures in Group 4 that are
similar to those of the rest of the arrays.
We further use other quality assessment methods to assess
the performance of MDQC. As some of these methods are
computationally intensive or difficult to visualize in large
studies, we select 12 potentially bad arrays and 10 good arrays
based on the MDQC diagnostic and the inspection of the image
files. We examine the histogram of probe-level data, the
MA-plots and perform a PLM QC assessment (Bolstad et al.,
2005), including the inspection of array pseudo-images, RNA-
degradation plots, relative log expressions (RLE) and normal-
ized unscaled standard errors (NUSE). Here, we briefly
describe the last quality measure and present its results for
our data. The conclusions are similar for the other measures
(see Supplementary Material).
The box plots in Figure 6 show the NUSE for the selected
arrays. These errors are the standard error between probe
intensities within a probe set for each array, normalized by
dividing all values of a particular probe set by the median
standard error for that probe set across arrays (Bolstad et al.,
2005). Their box plots are expected to be small and centered at
one reflecting a small variability within the probe sets of an
array. It is noticeable that those arrays identified by MDQC as
having potential quality problems are also flagged by this
quality measure (similar results are found using other
diagnostic plots of PLM available in Supplementary
Material). Their boxes are larger and in most cases not centered
at one, indicating the existence of more outlying probes in those
arrays with a larger variability within probe sets than in other
arrays. In sum, the MDQC method is comparable in its
effectiveness as the PLM method. Its main advantage over the
PLM method is that it is not computer memory intensive, and
is much more suitable for assessing the quality of a large
number of arrays.
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4 CONCLUSION
We propose a new method (MDQC) to identify potentially low-
quality arrays. Its advantage is that it has a clear statistical
foundation, it uses the correlation structure of the various QC
measures, it is easy to apply, and it is computationally light-
weight. These properties make MDQC a useful diagnostic
technique suitable for large datasets. MDQC performs a robust
multivariate analysis of the quality measures provided in the
QC report while taking into account their correlation structure.
More precisely, the method first identifies the typical quality
measures of valid arrays using robust estimators of the center
and correlation structure. It then uses the MD based on these
estimators to flag arrays with quality measures that are far from
those of valid ones. We show that a multivariate analysis gives
substantially richer information than the inspection of individ-
ual measures in isolation. Moreover, the method gives a simple
way to compare the quality across arrays that is useful to rank
them according to their quality and to flag those likely to be
defective. Finally, we show that computing these distances on
subsets of the quality measures in the report, instead of on all of
them, may increase the method’s ability to detect unusual
arrays. In our case studies, we find that the a priori grouping
method and the global PCA identify almost the same set of
multivariate outliers. However, using the a priori method, the
interpretability of the groups may be used to provide useful
information about the likely source of potential quality
problem.
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